SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Heba Elrashidy, Gamal El-Didamony, Ashraf Elbahrawy, Alaa Hashim, Ahmed Alashker, Mohamed Hanafy Morsy, Ahmed Elwassief, Amr Elmestikawy, Abdallah Mahmoud Abdallah, Abdel-Gawad Saeid Mohammad, Mohamed Mostafa, Nilly M George, Hafez Abdelhafeez, Absence of occult hepatitis B virus infection in sera of diabetic children and adolescents following hepatitis B vaccination, Human vaccines & immunotherapeutics, 2014, 10, 8

    CrossRef

  2. 2
    Edina Amponsah-Dacosta, Ramokone L. Lebelo, J. Nare Rakgole, Rosemary J. Burnett, Selokela G. Selabe, M. Jeffrey Mphahlele, Evidence for a change in the epidemiology of hepatitis B virus infection after nearly two decades of universal hepatitis B vaccination in South Africa, Journal of Medical Virology, 2014, 86, 6
  3. 3
    Terence T. Lao, K.L. Cheung, Vincent Wong, Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women, Vaccine, 2014,

    CrossRef

  4. 4
    T-W Wu, C-C Chu, H-W Chang Liao, S-K Lin, T-Y Ho, M Lin, H H Lin, L-Y Wang, HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy, Genes and Immunity, 2014, 15, 1, 47

    CrossRef

  5. 5
    Andréa do Livramento, Júnia Schultz, Keila Zaniboni Siqueira Batista, Arício Treitinger, Caio Maurício Mendes de Cordova, Celso Spada, Immune memory response induced in vitro by recombinant hepatitis B surface antigen challenge 13–18 years after primary vaccination, Journal of Medical Virology, 2014, 86, 9
  6. 6
    Tzu-Wei Wu, Hans Hsienhong Lin, Li-Yu Wang, Reply, Hepatology, 2014, 59, 1
  7. 7
    Reza Norouzirad, Abdol Hussein Shakurnia, Mohammad-Ali Assarehzadegan, Amirarsalan Serajian, Mehdi Khabazkhoob, Serum Levels of Anti-Hepatitis B Surface Antibody Among Vaccinated Population Aged 1 to 18 Years in Ahvaz City Southwest of Iran, Hepatitis Monthly, 2014, 14, 1

    CrossRef

  8. 8
    Heba Elrashidy, Ashraf Elbahrawy, Gamal El-Didamony, Mohamed Mostafa, Nilly M. George, Ahmed Elwassief, Abdel-Gawad Saeid Mohamed, Amr Elmestikawy, Mohamed Hanafy Morsy, Alaa Hashim, Mohamed Ali Abdelbasseer, Antibody levels against hepatitis B virus after hepatitis B vaccination in Egyptian diabetic children and adolescents, Human vaccines & immunotherapeutics, 2013, 9, 9, 2002

    CrossRef

  9. 9
    Tzu-Wei Wu, Hans Hsienhong Lin, Li-Yu Wang, Chronic hepatitis B infection in adolescents who received primary infantile vaccination, Hepatology, 2013, 57, 1
  10. 10
    Katharina Schönberger, Christina Riedel, Simon Rückinger, Ulrich Mansmann, Wolfgang Jilg, Rüdiger v. Kries, Determinants of Long-term Protection After Hepatitis B Vaccination in Infancy, The Pediatric Infectious Disease Journal, 2013, 32, 4, 307

    CrossRef

  11. 11
    T. T. LAO, D. S. SAHOTA, S. S. H. SUEN, P. K. S. CHAN, T. Y. LEUNG, Impact of neonatal hepatitis B vaccination programme on age-specific prevalence of hepatitis B infection in teenage mothers in Hong Kong, Epidemiology and Infection, 2013, 141, 10, 2131

    CrossRef

  12. 12
    Yong Poovorawan, Voranush Chongsrisawat, Apiradee Theamboonlers, Priya Diana Crasta, Marc Messier, Karin Hardt, Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: A 20-year follow-up study in Thailand, Human vaccines & immunotherapeutics, 2013, 9, 8, 1679

    CrossRef

  13. 13
    Tzu-Wei Wu, Chen-Chung Chu, Tzu-Ying Ho, Huei-Wen Chang Liao, Sheng-Kai Lin, Marie Lin, Hans Hsienhong Lin, Li-Yu Wang, Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents, Human Genetics, 2013, 132, 10, 1131

    CrossRef

  14. 14
    Marta C Nunes, Shabir A Madhi, Review of a new fully liquid, hexavalent vaccine: Hexaxim, Expert Opinion on Biological Therapy, 2013, 13, 4, 575

    CrossRef

  15. 15
    Jens M. Werner, Adil Abdalla, Naveen Gara, Marc G. Ghany, Barbara Rehermann, The Hepatitis B Vaccine Protects Re-Exposed Health Care Workers, But Does Not Provide Sterilizing Immunity, Gastroenterology, 2013, 145, 5, 1026

    CrossRef

  16. 16
    Adam J. Shapiro, Charles R. Esther, Margaret W. Leigh, Elisabeth P. Dellon, Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease, Vaccine, 2013, 31, 6, 906

    CrossRef

  17. 17
    Pierre Van Damme, John Ward, Daniel Shouval, Steven Wiersma, Alessandro Zanetti, Vaccines, 2013,

    CrossRef

  18. 18
    Govind Prasad Sahu, Joydip Dhar, Analysis of an SVEIS epidemic model with partial temporary immunity and saturation incidence rate, Applied Mathematical Modelling, 2012, 36, 3, 908

    CrossRef

  19. 19
    Tung-Hung Su, Pei-Jer Chen, Emerging hepatitis B virus infection in vaccinated populations: a rising concern?, Emerging Microbes & Infections, 2012, 1, 9, e27

    CrossRef

  20. 20
    Miguel Ortín, Muhammad A Saif, How necessary is it to revaccinate hemopoietic transplant recipients?, Immunotherapy, 2012, 4, 5, 461

    CrossRef

  21. 21
    Katharina Schönberger, Christina Riedel, Simon Rückinger, Ulrich Mansmann, Wolfgang Jilg, Rüdiger von Kries, Impact of maternal carrier status on immunologic markers for protection after hepatitis B vaccination in infancy: A meta-analysis, Vaccine, 2012, 30, 44, 6314

    CrossRef

  22. 22
    Ming–Wei Lai, Tzou–Yien Lin, Kuo–Chien Tsao, Chung–Guei Huang, Mei–Jen Hsiao, Kung–Hao Liang, Chau–Ting Yeh, Increased Seroprevalence of HBV DNA With Mutations in the S Gene Among Individuals Greater Than 18 Years Old After Complete Vaccination, Gastroenterology, 2012, 143, 2, 400

    CrossRef

  23. 23
    Yen-Hsuan Ni, Mei-Hwei Chang, Jia-Feng Wu, Hong-Yuan Hsu, Huey-Ling Chen, Ding-Shinn Chen, Minimization of hepatitis B infection by a 25-year universal vaccination program, Journal of Hepatology, 2012, 57, 4, 730

    CrossRef

  24. 24
    Yong Poovorawan, Voranush Chongsrisawat, Apiradee Theamboonlers, Geert Leroux-Roels, Priya Diana Crasta, Karin Hardt, Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers, Human vaccines & immunotherapeutics, 2012, 8, 7, 896

    CrossRef

  25. 25
    Cenk Aypak, Adnan Yüce, Hülya Yıkılkan, Süleyman Görpelioğlu, Persistence of protection of hepatitis B vaccine and response to booster immunization in 2- to 12-year-old children, European Journal of Pediatrics, 2012, 171, 12, 1761

    CrossRef

  26. 26
    Fu-Hsiung Su, Chyi-Huey Bai, Fang-Yeh Chu, Yu-Shiang Lin, Chien-Tien Su, Chih-Ching Yeh, Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan, Vaccine, 2012, 30, 27, 4034

    CrossRef

  27. 27
    E. Leuridan, P. Van Damme, Hepatitis B and the Need for a Booster Dose, Clinical Infectious Diseases, 2011, 53, 1, 68

    CrossRef

  28. 28
    Li-Min Huang, Chun-Yi Lu, Ding-Shinn Chen, Hepatitis B virus infection, its sequelae, and prevention by vaccination, Current Opinion in Immunology, 2011, 23, 2, 237

    CrossRef

  29. 29
    Ying-Ju Lin, Yu-Ching Lan, Lei Wan, Ting-Hsu Lin, Da-Yuan Chen, Chang-Hai Tsai, Chiu-Shong Liu, Kai-Chung Hsueh, Fuu-Jen Tsai, Serological surveillance and IL-10 genetic variants on anti-HBs titers: Hepatitis B vaccination 20years after neonatal immunization in Taiwan, Clinica Chimica Acta, 2011, 412, 9-10, 766

    CrossRef

  30. 30
    Ching-Chiang Lin, Chun-Yuh Yang, Ching-Tang Shih, Bai-Hsiun Chen, Yeou-Lih Huang, Waning immunity and booster responses in nursing and medical technology students who had received plasma-derived or recombinant hepatitis B vaccine during infancy, American Journal of Infection Control, 2011, 39, 5, 408

    CrossRef

  31. 31
    Chyi-Feng Jan, Kuo-Chin Huang, Yin-Chu Chien, Donald E. Greydanus, H. Dele Davies, Tai-Yuan Chiu, Li-Min Huang, Chien-Jen Chen, Ding-Shinn Chen, Determination of immune memory to hepatitis B vaccination through early booster response in college students, Hepatology, 2010, 51, 5
  32. 32
    Y.-H. Ni, D.-S. Chen, Hepatitis B vaccination in children: The Taiwan experience, Pathologie Biologie, 2010, 58, 4, 296

    CrossRef

  33. 33
    Mei Hwei Chang, Hepatitis B Vaccination: Disease and Cancer Prevention—A Taiwanese Experience, Clinics in Liver Disease, 2010, 14, 3, 521

    CrossRef

  34. 34
    J. Metodi, S. Aboud, R. Mpembeni, E. Munubhi, Immunity to hepatitis B vaccine in Tanzanian under-5 children, Annals of Tropical Paediatrics, 2010, 30, 2, 129

    CrossRef

  35. 35
    Miguel W. Tregnaghi, Ricardo Voelker, Eduardo Santos-Lima, Betzana Zambrano, Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10–45 years, Vaccine, 2010, 28, 20, 3595

    CrossRef

  36. 36
    S. Agladioglu, U. Beyazova, A. D. Camurdan, F. Sahin, A. Atak, Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules, Infection, 2010, 38, 4, 269

    CrossRef

  37. 37
    S. S. H. Suen, T. T. Lao, D. S. Sahota, T. K. Lau, T. Y. Leung, Implications of the relationship between maternal age and parity with hepatitis B carrier status in a high endemicity area, Journal of Viral Hepatitis, 2010, 17, 5
  38. 38
    Mitchell L. Shiffman, Management of Acute Hepatitis B, Clinics in Liver Disease, 2010, 14, 1, 75

    CrossRef

  39. 39
    Libin Xu, Yong Wei, Taoyang Chen, Jianhua Lu, Chang-Lin Zhu, Zhengping Ni, Fei Huang, Jun Du, Zongtang Sun, Chunfeng Qu, Occult HBV infection in anti-HBs-positive young adults after neonatal HB vaccination, Vaccine, 2010, 28, 37, 5986

    CrossRef

  40. 40
    L. Bracciale, M. Fabbiani, A. Sansoni, L. Luzzi, L. Bernini, G. Zanelli, Impact of Hepatitis B Vaccination in Children Born to HBsAg-Positive Mothers: a 20-year Retrospective Study, Infection, 2009, 37, 4, 340

    CrossRef

  41. 41
    Lokman Uzun, Rıdvan Say, Serhat Ünal, Adil Denizli, Production of surface plasmon resonance based assay kit for hepatitis diagnosis, Biosensors and Bioelectronics, 2009, 24, 9, 2878

    CrossRef

  42. 42
    Koen Van Herck, Pierre Van Damme, Benefits of Early Hepatitis B Immunization Programs for Newborns and Infants, The Pediatric Infectious Disease Journal, 2008, 27, 10, 861

    CrossRef

  43. 43
    Paloma Jara, Miguel Bruguera, Hepatitis B en gestantes y niños, Enfermedades Infecciosas y Microbiología Clínica, 2008, 26, 66

    CrossRef

  44. 44
    Mindie H. Nguyen, Huy N. Trinh, Ruel Garcia, Gloria Nguyen, Khoa D. Lam, Emmet B. Keeffe, Higher Rate of Sustained Virologic Response in Chronic Hepatitis C Genotype 6 Treated With 48 Weeks Versus 24 Weeks of Peginterferon Plus Ribavirin, The American Journal of Gastroenterology, 2008, 103, 5, 1131

    CrossRef

  45. 45
    Hans Hsienhong Lin, Huei-Wen Chang Liao, Sheng-Kai Lin, Li-Yu Wang, HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination, Vaccine, 2008, 26, 27-28, 3414

    CrossRef

  46. 46
    Chun-Yi Lu, Yen-Hsuan Ni, Bor-Luen Chiang, Pei-Jer Chen, Mei-Hwei Chang, Luan-Yin Chang, Ih-Jen Su, Hsu-Sung Kuo, Li-Min Huang, Ding-Shinn Chen, Chin-Yun Lee, Humoral and Cellular Immune Responses to a Hepatitis B Vaccine Booster 15–18 Years after Neonatal Immunization, The Journal of Infectious Diseases, 2008, 197, 10, 1419

    CrossRef

  47. 47
    Faleh AlFaleh, Suliman AlShehri, Saleh AlAnsari, Mohammed AlJeffri, Yaqoub AlMazrou, Ahmad Shaffi, Ayman A. Abdo, Long-term protection of hepatitis B vaccine 18 years after vaccination, Journal of Infection, 2008, 57, 5, 404

    CrossRef

  48. 48
    Stephanie R. Bialek, William A. Bower, Ryan Novak, Louisa Helgenberger, Steven B. Auerbach, Ian T. Williams, Beth P. Bell, Persistence of Protection Against Hepatitis B Virus Infection Among Adolescents Vaccinated With Recombinant Hepatitis B Vaccine Beginning at Birth, The Pediatric Infectious Disease Journal, 2008, 27, 10, 881

    CrossRef

  49. 49
    Yen-Hsuan Ni, Ming-Chih Ho, Jia-Feng Wu, Huey-Ling Chen, Yao-Ming Wu, Rey-Heng Hu, Po-Huang Lee, Mei-Hwei Chang, Response to Booster Hepatitis B Vaccines in Liver-Transplanted Children Primarily Vaccinated in Infancy, Transplantation, 2008, 86, 11, 1531

    CrossRef

  50. 50
    David Yiu-Kuen But, Ching-Lung Lai, Wei-Ling Lim, James Fung, Danny Ka-Ho Wong, Man-Fung Yuen, Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report, Vaccine, 2008, 26, 51, 6587

    CrossRef

  51. 51
    F.-H. Su, J.-D. Chen, S.-H. Cheng, K.-Y. Sung, J.-J. Jeng, F.-Y. Chu, Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan’s national hepatitis B vaccination programme, Journal of Viral Hepatitis, 2008, 15, 1
  52. 52
    Li-Yu Wang, Hans Hsienhong Lin, Ethnicity, substance use, and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination, Journal of Hepatology, 2007, 46, 6, 1018

    CrossRef

  53. 53
    Fu-Hsiung Su, Shu-Hsing Cheng, Chung-Yi Li, Jong-Dar Chen, Chih-Yin Hsiao, Chih-Ching Chien, Ya-Chuan Yang, Hsiu-Hsing Hung, Fang-Yeh Chu, Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination, Vaccine, 2007, 25, 47, 8085

    CrossRef

  54. 54
    Ching-Chiang Lin, Chen-Kang Chang, Yeou-Lih Huang, Hung-Fu Tseng, Low seroprevalence of hepatitis B surface antibody among nursing students in Taiwan: An implication for boosting, Vaccine, 2007, 25, 51, 8508

    CrossRef

  55. 55
    Hsien-Cheng Chang, Chung-Jen Yen, Yi-Chin Lee, Tai-Yuan Chiu, Chyi-Feng Jan, Seroprevalence of Hepatitis B Viral Markers Among Freshmen — 20 Years After Mass Hepatitis B Vaccination Program in Taiwan, Journal of the Formosan Medical Association, 2007, 106, 7, 513

    CrossRef

  56. 56
    Fu-Hsiung Su, Jong-Dar Chen, Shu-Hsing Cheng, Ching-Hung Lin, Yi-Hui Liu, Fang-Yeh Chu, Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program, Journal of Medical Virology, 2007, 79, 2
  57. 57
    Li-Yu Wang, Hans Hsienhong Lin, Short-term response to a booster dose of hepatitis B vaccine in anti-HBs negative adolescents who had received primary vaccination 16 years ago, Vaccine, 2007, 25, 41, 7160

    CrossRef

  58. 58
    Yen–Hsuan Ni, Li–Min Huang, Mei–Hwei Chang, Chung–Jen Yen, Chun–Yi Lu, San–Lin You, Jia–Horng Kao, Yu–Chen Lin, Huey–Ling Chen, Hong–Yuan Hsu, Ding–Shinn Chen, Two Decades of Universal Hepatitis B Vaccination in Taiwan: Impact and Implication for Future Strategies, Gastroenterology, 2007, 132, 4, 1287

    CrossRef

  59. You have free access to this content59
    Jye-Bin Lin, Ding-Bang Lin, Shiuan-Chih Chen, Pao-San Chen, Wen-Kang Chen, Seroepidemiology of hepatitis A, B, C, and E viruses infection among preschool children in Taiwan, Journal of Medical Virology, 2006, 78, 1
  60. 60
    Stephen N Wong, Anna SF Lok, Update on viral hepatitis: 2005, Current Opinion in Internal Medicine, 2006, 5, 4, 392

    CrossRef

  61. 61
    Alex Yui Hui, Joseph Jao-Yiu Sung, Advances in chronic viral hepatitis, Current Opinion in Infectious Diseases, 2005, 18, 5, 400

    CrossRef

  62. 62
    Alex Yui Hui, Joseph Jao-Yiu Sung, Advances in chronic viral hepatitis, Current Opinion in Internal Medicine, 2005, 4, 6, 548

    CrossRef

  63. 63
    Jia-Horng Kao, Ding-Shinn Chen, Hepatitis B vaccination: to boost or not to boost?, The Lancet, 2005, 366, 9494, 1337

    CrossRef

  64. 64
    Melissa S Lee, Henry H Bernstein, Immunizations, neonatal jaundice, and animal-induced injuries, Current Opinion in Pediatrics, 2005, 17, 3, 418

    CrossRef

  65. 65
    Cho-Yu Chan, Shou-Dong Lee, More on the need for boosters 15 years after neonatal vaccination, Hepatology, 2005, 41, 4
  66. 66
    Edward Tabor, Persistence of antibody after hepatitis B vaccine and the question of boosters, Hepatology, 2005, 41, 4
  67. 67
    Maria H. Sjogren, Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination, The American Journal of Medicine, 2005, 118, 10, 34

    CrossRef

  68. 68
    Chun-Yi Lu, Yen-Hsuan Ni, Mei-Hwei Chang, Chin-Yun Lee, Li-Min Huang, Reply:, Hepatology, 2005, 41, 4
  69. 69
    Jalal Poorolajal, Mahmood Mahmoodi, AliAkbar Haghdoost, Reza Majdzadeh, Siavosh Nasseri-Moghaddam, Leila Ghalichi, Akbar Fotouhi, Booster dose vaccination for preventing hepatitis B, The Cochrane Library,
  70. 70
    Anna S. F. Lok, Francesco Negro, Hepatitis B and D,